December, 2021

article thumbnail

The Laboratory community bounces back at Lab Innovations~ A round-up of Lab Innovations 2021 ~

Drug Discovery Today

Lab Innovations, the UK’s largest trade exhibition for the laboratory industry, returned to the NEC, Birmingham, on November 3 and 4, 2021 and brought the laboratory community together for the first time after almost two years apart. With 3,117 visitors, the show gave the industry’s leading professionals and companies the chance to meet face-to-face, network and discover the latest innovations.

article thumbnail

Why GoodRx—Not Amazon—May Be the True PBM Disrupter (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. Click here to see the original post and comments from August 2021. The generic prescription market is being disrupted—but not by the big, bad spaceman from Seattle. Instead, consider how GoodRx is affecting patients, payers, and PBMs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Which pharmaceutical companies have the most drug patents in Czech Republic?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical companies have the most drug patents in Czech Republic? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

The Definition of “Fully Vaccinated” Needs to Change

Eye on FDA

The COVID-19 pandemic is a rapidly changing landscape. We are long gone from the days of being threatened by a rampant Alpha virus to having several successive variants. It now appears that the very fast-spreading Omicron may become dominant over yesterday’s Delta variant. We now have multiple vaccines – mRNA and traditional in the U.S. and an even greater array outside the U.S.

Vaccine 72
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

The Domain Reform for Unlawful Drug Sellers Act is Big Pharma’s Bill

Policy Prescription

UPDATE : Senator Amy Klobuchar (D-MN) has withdrawn her sponsorship and support for this bill. A new bill introduced by Sens. Mark Rubio (R-FL) and Amy Klobuchar (D-MN) , called the “Domain Reform for Unlawful Drug Sellers Act’’ or, for short, the ‘‘DRUGS Act,’’ could effectively end online access to safe and affordable imported medicines for Americans.

article thumbnail

How to Tell the Difference Between Migraines and Headaches

Olympian Clinical Research

Headaches are one of the most common medical complaints and can range from mild to severe. But how do you know if the pain in your head is from a headache or something more serious? Many people struggle to differentiate between a typical headache and a migraine, which is a chronic headache disorder. What is a Headache? A headache is a condition that causes pain in the head, face, or neck, and there are more than 150 types, falling into two main categories: primary and secondary headaches. .

More Trending

article thumbnail

PBMs and Drug Spending in 2020: Data from CVS Health (sort of), Express Scripts, Navitus, and WellDyne (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. Click here to see the original post and comments from July 2021. Since 2012, Drug Channels has examined commercial drug spending using the annual trend reports published by the largest PBMs. This year, we review 2020 data on commercial plan sponsor clients of CVS Health and Express Scripts along with two smaller PBMs—Navitus and WellDyne.

article thumbnail

Which pharmaceutical companies have the most drug patents in Brazil?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Brazil. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Brazil? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

CDER & CBER Real World Data and Real World Evidence

Pharmaceutical Development Group

Start Up and Generic Pharmaceutical Drug and Biologic Companies have high quality, affordable products that improve the quality of life for their patients. However, this often is associated with austere conditions wherein time and funds are both in short supply. Effective use of Real World Data (RWD) and Real World Evidence (RWE) can reduce costs of Pharmaceutical Drug and Biologic Products and Process Development, Drug Development Services , expedite a FDA Pre-Submission Review, and lead to FDA

article thumbnail

Expansions, transactions and all action: Our 2021 recap!

Sygnature Discovery

2021 is nearly over – and what a year it’s been for Sygnature! From key appointments to new investment and growth across the pond, there have been plenty of reasons to get out the party poppers despite the ongoing pandemic (in a safe fashion, obviously). Let’s remind ourselves of a great 12 months… The successes started early when we were named Company of the Year at the slightly delayed 2020 Bionow Annual Awards in February.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

High Content What? Deciphering between High-Content Imaging (HCI), High-Content Screening (HCS), and High-Content Analysis (HCA)

Crown Bioscience

In this post, we explore the differences between the terms high-content imaging (HCI), high-content screening (HCS), and high-content analysis (HCA), and why these automated and image-based high-throughput technologies are increasingly being adopted to generate data to facilitate preclinical studies and downstream go/no-go decision-making.

52
article thumbnail

15th Edition Pharma Resource Planning and Portfolio OptimizationPhiladelphia, PA | Option to attend virtuallyFebruary 22-24, 2022 | 08:30 EDT

Drug Discovery Today

Directing Strategy, Decision Making and Resource Optimization for Optimal Portfolio Success

100
100
article thumbnail

Drug Channels News Roundup, December 2021: CAR-T Profits, UM Boom, Health Plans vs. Experts, Confused Physicians, and Health Insurance Explained

Drug Channels

Happy New Year, everyone! We made it through a challenging 2021. Ring in 2022 with these noisemakers from the Drug Channels party bag: Hospitals earn incredible markups on CAR-T therapies Utilization management booms Health plans often ignore clinical guidelines Benefit designs flummox physicians Plus: an awesomely concise summary of U.S. health insurance.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Eurasian Patent Organization?

Drug Patent Watch

This chart shows the drugs with the most patents in Eurasian Patent Organization. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical drugs have the most drug patents in Eurasian Patent Organization? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Drug development strategy for US FDA

ProRelix Research

­­Drug development strategy for US FDA It takes a staggering 12 years on an average for a drug to travel from the laboratory bench to your bedside! This is coupled […]. The post Drug development strategy for US FDA appeared first on ProRelix Research.

article thumbnail

Accelerating Riboswitch Engineering for the Development of Human Performance Biosensors - A Preview of Strateos’ Presentation at SynBioBeta 2021

The Strateos Blog: Drug Discovery

SynBioBeta 2021 – the Global Synthetic Biology Conference – will take place between January 25th - 27th 2022 in Oakland, California. Strateos’ own Daniel Rines, Ph.D., Senior Director, R&D Strategy, will be delivering a presentation highlighting how Strateos' smart lab platform accelerated riboswitch engineering to develop novel biosensors.

article thumbnail

Pharmaceutical Innovation and Agility

EG Life Sciences

For some time, Eliassen Group and EG Life Sciences have been working together to tackle the challenges faced by pharmaceutical companies as they innovate to keep up with a rapidly changing landscape. As part of that, we have invited members of the pharmaceutical industry and Agile experts to lean coffees that discuss ways to bring Agile and biopharma together to speed up delivery, unlock operational excellence, and improve lives.

article thumbnail

CENTOGENE Wins Award in Digital Healthcare Innovation for Artificial Intelligence (AI) Platform Leading Biomarker Discovery

Drug Discovery Today

Leveraging AI to Accelerate the Path From Diagnosis to Cure

100
100
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

A Video History of Pharmacies and Prescription Prices: From Soda Fountains to GoodRx (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. Click here to see the original post and comments from August 2021. Charlotte Morabito at CNBC has put together “Why Pharmacies Overcharge,” an entertaining and provocative video on the pharmacy industry and its generic prescription pricing.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Norway?

Drug Patent Watch

This chart shows the drugs with the most patents in Norway. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Norway? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the Ongoing Open-Label SHORELINE Study in Patients with MDD

The Pharma Data

In the zuranolone 50 mg cohort, the majority of patients who responded to an initial 14-day course received only one two-week course of treatment during the study and nearly 80% received only one or two treatment courses in total. Zuranolone 50 mg was generally well-tolerated with an overall adverse event profile consistent with data reported earlier and 6.5% of patients discontinuing study drug due to adverse events.

article thumbnail

Accelerating Medicinal Chemistry Cycle Times Through Cloud-Accessible Smart Automated Labs - A Preview of Strateos’ Presentation at SLAS 2022

The Strateos Blog: Drug Discovery

We are excited to share that Strateos’ SVP of Strategy & Operations, Daniel Sipes, will be delivering a presentation entitled Accelerating Medicinal Chemistry Cycle Times Through Cloud-Accessible Smart Automated Labs at the upcoming 2022 Society for Laboratory Automation and Screening Conference & Exhibition between February 5-9th. SLAS 2022 is set to be an exciting conference where scientists can come together to learn about the innovative technologies transforming the way life s

article thumbnail

Allosteric Modulators of GPCRs: A Promising Approach for Drug Discovery

PerkinElmer

G-protein coupled receptors (GPCRs) are the largest and most diverse family of membrane receptors in the human genome and are targeted by around one third of drugs currently approved by the FDA. These proteins represent one of the most extensively studied targets for drug discovery, mainly due to their involvement in a plethora of signaling pathways and pathophysiological processes in the human body.

Drugs 52
article thumbnail

Understanding the Clinical Trial Process

Olympian Clinical Research

The clinical trial process can be a complicated but rewarding one. There are many different types of trials and even more ways to participate in them. Therefore, fully understanding the clinical trial process can help you get the most out of any study that you choose to participate in. What is a Clinical Trial? A clinical trial is a medical research study designed to provide data for new and existing treatment methods.

article thumbnail

How CVS Health Drives Cardinal Health’s Distribution Financials (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Outlook 2022. Hope you can join me! Click here to see the original post and comments from September 2021. Cardinal Health recently released the annual report for its 2021 fiscal year, which ended on June 30. See the links below. Today, I delve into the financials behind Cardinal’s relationship with its largest customer, CVS Health.

article thumbnail

Which pharmaceutical companies have the most concentrate dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most concentrate dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most concentrate dosed drugs…. The post Which pharmaceutical companies have the most concentrate dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Teva Announces Launch of an Authorized Generic of Epiduo® Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the U.S.

The Pharma Data

TEL AVIV & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of an authorized generic of Epiduo® 1 Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the United States. Adapalene and benzoyl peroxide gel 0.3%/2.5% is a topical prescription medicine used to treat acne vulgaris.

Doctors 52
article thumbnail

New patent for Teva Branded drug PROAIR RESPICLICK

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 84
article thumbnail

New patent for Amgen Inc drug CORLANOR

Drug Patent Watch

Annual Drug Patent Expirations for CORLANOR Corlanor is a drug marketed by Amgen Inc and is included in two NDAs. It is available from one supplier. There are eight patents…. The post New patent for Amgen Inc drug CORLANOR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 84
article thumbnail

New patent for Allergan Holdings drug VIBERZI

Drug Patent Watch

Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are sixteen patents…. The post New patent for Allergan Holdings drug VIBERZI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 81
article thumbnail

Which pharmaceutical companies have the most drug patents in Spain?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Spain? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

New patent for Acadia Pharms drug NUPLAZID

Drug Patent Watch

Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are eighteen…. The post New patent for Acadia Pharms drug NUPLAZID appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 80
article thumbnail

Which pharmaceutical companies have the most cream dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most cream dosed drugs…. The post Which pharmaceutical companies have the most cream dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.